COVID-19
How COVID-19 has affected the oncology drugs market
January 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer
In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
Lilly’s antibody could reduce COVID-19 risk by 80%, trial shows
January 22, 2021Medical Communications COVID-19, Eli Lilly
Eli Lilly’s neutralising antibody bamlanivimab significantly reduced the risk of contracting symptomatic coronavirus among residents and staff of long-term care …
Thousands of Israelis test positive for COVID-19 after receiving Pfizer jab
January 21, 2021COVID-19, Pfizer, israel
Thousands of people in Israel have tested positive for coronavirus after receiving the Pfizer vaccine, including some who had been …
Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says
January 20, 2021Research and Development COVID-19, Pfizer
The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …
Bharat Biotech advises certain groups against taking its COVID-19 vaccine
January 19, 2021Manufacturing and Production Bharat Biotech, COVID-19
India’s vaccine developer Bharat Biotech has advised a number of groups to avoid taking its homegrown COVID-19 vaccine, Covaxin. According …
ConserV and Lawrence Livermore National Laboratory to collaborate on coronavirus vaccine
January 19, 2021Manufacturing and Production COVID-19, ConserV Bioscience
ConserV Bioscience, a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and Lawrence …
Pharmafile.com’s top 10 news stories of the week
January 15, 2021Medical Communications COVID-19
Pharmafile.com’s most popular stories this week include the use of two new, potentially life-saving treatments for on COVID-19 patients, and …
Alexion pauses Phase III ULTOMIRIS COVID-19 trial enrolment
January 15, 2021Medical Communications Alexion, COVID-19
Alexion has paused further enrolment in the global Phase III study of ULTOMIRIS (ravulizumab-cwvz) in adult COVID-19 patients requiring mechanical …
Celltrion announces positive top-line results from COVID-19 treatment trial
January 14, 2021COVID-19, celltrion
Celltrion Group has announced that top-line results from its global Phase II/III clinical trial of CT-P59, an anti-COVID-19 monoclonal antibody …
Trial of potential new COVID-19 treatment begins in UK
January 13, 2021Research and Development COVID-19, Synairgen, Vaccine
A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …
Switzerland approves Moderna’s COVID-19 vaccine
January 13, 2021Research and Development COVID-19, Moderna, Vaccine
Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …
AstraZeneca seeks EU approval for COVID-19 vaccine
January 12, 2021Manufacturing and Production AstraZeneca, COVID-19, Vaccine
AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …
Seven mass vaccination sites open in England
January 11, 2021Sales and Marketing COVID-19, UK, Vaccine
Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …
Pfizer’s COVID-19 vaccine protects against variants, research shows
January 8, 2021Medical Communications COVID-19, Pfizer, Vaccine
Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …
Bayer and CureVac to collaborate on COVID-19 vaccine candidate
January 8, 2021Medical Communications Bayer, COVID-19, Vaccine
Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
